Search

everythinglearnresearchcommunity

for

Search:↓

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Effective PCOS treatments require targeting specific signaling pathways.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Both mouse and rat models are effective for testing alopecia areata treatments.

Some drugs used to treat inflammation may cause hair loss.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Eating fewer calories may slow aging and removing old cells can increase lifespan in mice.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Zinc is crucial for skin health and treating various skin disorders.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

New nanocarriers improve drug delivery for disease treatment.